CB

Chirag Bhupendrabhai Gosalia

Active Director Director DIN 06852278
DIN 06852278 First appointment Apr 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2014
Shareholding value •••• Premium profile

About Chirag Bhupendrabhai Gosalia

Data last updated:

Chirag Bhupendrabhai Gosalia is a Director at Walnut Pharma Private Limited (since 2014). The company operates in Pharma. Walnut Pharma Private Limited reported revenue of ₹6.16 Cr (FY 2025).

DIN 06852278
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2014
Oldest Company Age 12 yrs
Largest company Walnut Pharma Private Limited · ₹6.16 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Walnut Pharma Private Limited U85100GJ2014PTC079507
Director01 Apr 20142014₹6.16 Cr (FY 2025)Active

Board colleagues of Chirag Bhupendrabhai Gosalia

Directorship timeline

Open interactive timeline →
Walnut Pharma Private Limited
Premium access

Shareholding and investment profile for Chirag Bhupendrabhai Gosalia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chirag Bhupendrabhai Gosalia

Chirag Bhupendrabhai Gosalia currently holds 1 directorship: Walnut Pharma Private Limited (Director, since 01 Apr 2014, revenue ₹6.16 Cr (FY 2025)).

Chirag Bhupendrabhai Gosalia was first appointed on 01 Apr 2014 as Director at Walnut Pharma Private Limited.

The current boards of Chirag Bhupendrabhai Gosalia's companies include Anujkumar Gangasaran Gupta (Walnut Pharma Private Limited), Kirankumar Patel (Walnut Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available